IC
ELAN icon

Inscription Capital’s Elanco Animal Health ELAN Stock Holding History

Inscription Capital’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Sell
13,042
-7,057
-35% -$163K 0.03% 521
2026
Q1 		$481K Hold
20,099
– – 0.05% 379
2025
Q4 		$455K Buy
+20,099
New +$437K 0.05% 389

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Inscription Capital's ELAN Position: Q2 2026 in Review

Inscription Capital reduced its Elanco Animal Health (ELAN) stake by 35% in Q2 2026, selling an estimated $163K and leaving 13,042 shares worth $321K. The position accounts for 0.03% of the portfolio, ranked #521.

Inscription Capital first reported a position in ELAN in Q4 2025 and has held it in 3 quarters since. The position peaked at $481K in Q1 2026. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Inscription Capital held 13,042 shares of Elanco Animal Health worth $321K as of Q2 2026.
  • Inscription Capital sold 7,057 Elanco Animal Health shares in Q2 2026, an estimated $163K.
  • Elanco Animal Health made up 0.03% of Inscription Capital's portfolio in Q2 2026, its #521 holding.
  • Inscription Capital first reported a position in Elanco Animal Health in Q4 2025 and has held it in 3 quarters since.
  • Inscription Capital's Elanco Animal Health position peaked at $481K in Q1 2026.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.